Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma

Abstract Background Pancreatic ductal adenocarcinoma (PDAC) remains a treatment-refractory malignancy with poor prognosis. It is urgent to identify novel and valid biomarkers to predict the progress and prognosis of PDAC. The S100A family have been identified as being involved in cell proliferation,...

Full description

Bibliographic Details
Main Authors: Hong-Bin Li, Jian-Li Wang, Xiao-Dong Jin, Lei Zhao, Hui-Li Ye, Yan-bei Kuang, Yong Ma, Xiang-Yan Jiang, Ze-Yuan Yu
Format: Article
Language:English
Published: BMC 2021-09-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-021-08769-6